122.90
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $122.90, with a volume of 4.24M.
It is down -2.72% in the last 24 hours and down -9.52% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$126.34
Open:
$125.2
24h Volume:
4.24M
Relative Volume:
2.07
Market Cap:
$34.76B
Revenue:
$6.95B
Net Income/Loss:
$1.30B
P/E Ratio:
26.90
EPS:
4.5696
Net Cash Flow:
$1.15B
1W Performance:
-2.31%
1M Performance:
-9.52%
6M Performance:
+3.18%
1Y Performance:
-10.15%
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies Inc
|
122.90 | 35.73B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
TMO
Thermo Fisher Scientific Inc
|
510.93 | 193.53B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
209.50 | 149.33B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
635.66 | 50.36B | 4.30B | 1.06B | 1.04B | 13.08 |
|
WAT
Waters Corp
|
333.33 | 32.24B | 3.17B | 642.63M | 539.81M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Initiated | HSBC Securities | Buy |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Oct-08-25 | Upgrade | UBS | Neutral → Buy |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
What is Agilent Technologies Inc.’s valuation compared to sectorQuarterly Profit Review & AI Driven Price Forecasts - mfd.ru
Stay Ahead of the Game With Agilent (A) Q1 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
Agilent Technologies Stock: Analyst Estimates & Ratings - inkl
Agilent Technologies Shares: Expert Predictions and Evaluations - Bitget
Ventana Companion Diagnostics Market is Going to Boom | Agilent - openPR.com
Gas Chromatography Systems Market to Reach US$7.20 Billion - openPR.com
Returns Recap: Should I buy Agilent Technologies Inc stock nowJuly 2025 Fed Impact & Fast Entry Momentum Alerts - baoquankhu1.vn
Agilent Technologies (A) Stock Analysis: Unpacking A 34.86% Potential Upside For Investors - DirectorsTalk Interviews
Earnings Risk: What is Agilent Technologies Incs valuation compared to sectorTrade Performance Summary & Low Drawdown Trading Strategies - baoquankhu1.vn
Published on: 2026-02-16 19:22:16 - baoquankhu1.vn
Aug Weekly: Whats the beta of Agilent Technologies Inc stockProduct Launch & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Agilent Technologies Stock: Quiet Rally, Hard Questions – Is The Lab Giant Still A Buy After Its C - AD HOC NEWS
Is Agilent Technologies Inc. stock considered safe havenAnalyst Upgrade & Accurate Entry/Exit Alerts - mfd.ru
The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - simplywall.st
Agilent Technologies, Inc. $A Shares Sold by ING Groep NV - MarketBeat
Can Agilent Technologies Inc. deliver alphaJuly 2025 Opening Moves & Stock Portfolio Risk Management - mfd.ru
Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A - MarketBeat
BofA Maintains Hold Rating on Agilent Technologies (A) After Q2 Report - MSN
How is Agilent Technologies' stock performance compared to other healthcare stocks? - MSN
Agilent Technologies, Inc.'s (NYSE:A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Agilent Technologies, Inc. $A Shares Sold by Rhumbline Advisers - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Agilent Technologies (NYSE:A) Boosts The S&P 500 Fund With Scientific Excellence - Kalkine Media
Agilent Technologies Inc (A) Shares Gap Down to $122.07 on Feb 1 - GuruFocus
Agilent Technologies, Inc. (NYSE:A) to Issue $0.26 Quarterly Dividend - MarketBeat
Press Release: Agilent Announces Cash Dividend of 25.5 Cents per Share - 富途牛牛
Agilent (A) Secures FDA Approval for Key Cancer Diagnostic Tool - GuruFocus
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC) - Business Wire
Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net
Agilent presents Boehringer Ingelheim with inaugural 2025 instrument Trade-in Impact Award - marketscreener.com
Is Agilent Technologies Inc. showing insider buyingRate Cut & Low Risk High Reward Trade Ideas - mfd.ru
Agilent Slumps After Awarding Boehringer - Baystreet.ca
Agilent's Ovarian Cancer Diagnostic Test Receives FDA Clearance - marketscreener.com
FDA Approval Boosts Agilent Technologies (A) Diagnostic Tool - GuruFocus
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - Bluefield Daily Telegraph
Madison Asset Management LLC Sells 14,089 Shares of Agilent Technologies, Inc. $A - MarketBeat
Gas Chromatography Detector Market Is Going to Boom |• Agilent Technologies • Thermo Fisher Scientific - openPR.com
Agilent Technologies, Inc. $A Position Cut by Impax Asset Management Group plc - MarketBeat
Agilent Technologies - Forbes
Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence - Quantisnow
Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A) - Yahoo Finance
Candriam S.C.A. Increases Holdings in Agilent Technologies, Inc. $A - MarketBeat
Envestnet Asset Management Inc. Raises Holdings in Agilent Technologies, Inc. $A - MarketBeat
Federated Hermes Inc. Has $273,000 Stock Position in Agilent Technologies, Inc. $A - MarketBeat
AGILENT TECHNOLOGIES, INC. ($A) CEO 2025 Pay Revealed - Quiver Quantitative
AAgilent Technologies Inc Stock Price and Quote - Finviz
What's Driving the Market Sentiment Around Agilent Technologies Inc? - Benzinga
Form DEFA14A AGILENT TECHNOLOGIES, - StreetInsider
Linscomb Wealth Inc. Invests $2.94 Million in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies (A) Valuation Check After New Automation And AI Lab Tools Showcase - Sahm
Agilent Showcases Next‑Generation Automated Solutions at SLAS2026 - BioSpace
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):